Skip to content

Abstract 18923: Prognostic Significance of Anticoagulation in Kidney Failure-Triggered Acute Illness Associated Atrial Fibrillation (AIAAF): The SAFE AF Study (Acronyms: SAFE-AF: Stroke Prevention, Anticoagulation, Fibrillation Control, Evaluation for Reversible Causes in Atrial Fibrillation)

Nov 2026 · Circulation · 0 citations

Abstract

Background: Current AHA and ESC guidelines acknowledge that standard risk scores are poorly calibrated for acute illness, leaving a gap in evidence-based management. Consequently, AIAAF in acute kidney failure often triggers therapeutic nihilism due to concerns of hemostatic fragility. Research Hypothesis: We investigated the independent association between anticoagulation (AC) and mortality in this population. Methods: We analyzed the SAFE AF multi-center cohort (N=4,193). The primary endpoint, 30-day all-cause mortality, was verified via state/national vital registries with 100% positive predictive value (PPV). To address known administrative coding inaccuracies for secondary endpoints, a rigorous manual adjudication protocol is actively underway. We utilized Fine-Gray models for competing risks, adjusting for age, sex, baseline systolic blood pressure, baseline BMI, and the Charlson Comorbidity Index (CCI). Results: AC use was independently associated with a 30-day survival advantage (HR 0.65, 95% CI 0.46-0.91, p=0.012). Overall survival at Day 30 was 96% for anticoagulated patients (AC+) versus 94% for non-anticoagulated patients (AC-). Furthermore, preliminary interim data from the ongoing adjudication process suggest AC is associated with a marked reduction in 30-day acute ischemic stroke (8.6% vs 19.0%; HR 0.46). AC is associated with reduction in major bleeding (4.5% vs 12.0%; HR 0.37) likely secondary to conservative prescription bias, where AC patients had significantly lower prior bleeding history (9.5% vs 12.3%, p=0.006) and lower CCI. Conclusion: In acute kidney failure, AIAAF is a marker of poor prognosis. The SAFE AF registry demonstrates a robust, independent survival association with AC use. These etiology-specific findings challenge the prevailing dogma of therapeutic nihilism and provide the objective, detailed outcome data required to guide safe clinical decision-making in a high-risk population.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.